XML 128 R117.htm IDEA: XBRL DOCUMENT v3.5.0.2
Guarantor Financial Information (Consolidating Statements of Income) (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Revenues:        
Product sales $ 3,315.4 $ 1,576.8 $ 7,264.8 $ 4,476.2
Royalties and other revenues 136.7 78.2 325.7 224.8
Total revenues 3,452.1 1,655.0 7,590.5 4,701.0
Costs and expenses:        
Cost of sales 1,736.2 262.7 2,762.9 718.5
Research and development 511.1 241.2 1,023.0 1,210.8
Selling, general and administrative 875.6 442.3 2,025.8 1,356.6
Amortization of acquired intangibles 354.9 132.7 702.5 352.3
Integration and acquisition costs 284.5 89.9 738.6 (46.8)
Reorganization costs 101.4 31.1 115.7 59.6
Other operating expenses   (0.7)   (13.0)
Gain on sale of product rights (5.7) (0.7) (12.2) (13.0)
Total operating expenses 3,858.0 1,199.2 7,356.3 3,638.0
Operating (loss)/income from continuing operations (405.9) 455.8 234.2 1,063.0
Interest income/(expense), net (177.6) (9.9) (306.9) (28.2)
Other income, net (13.7) 9.6 (16.2) 11.9
Total other expense, net (191.3) (0.3) (323.1) (16.3)
(Loss)/income from continuing operations before income taxes and equity in losses of equity method investees (597.2) 455.5 (88.9) 1,046.7
Income tax benefit/(expense) 229.6 22.3 218.4 9.0
Equity in income/(losses) of equity method investees, net of taxes 0.9 0.7 1.9 1.6
(Loss)/income from continuing operations, net of taxes (368.5) 477.1 127.6 1,054.1
Loss from discontinued operations, net of taxes (18.3) (24.3) (257.5) (31.3)
Net (loss)/income (386.8) 452.8 (129.9) 1,022.8
Comprehensive (loss)/income (135.2) 409.2 (80.3) 899.2
Eliminations        
Revenues:        
Product sales 0.0 0.0 0.0 0.0
Royalties and other revenues 0.0 0.0 0.0 0.0
Total revenues 0.0 0.0 0.0 0.0
Costs and expenses:        
Cost of sales 0.0 0.0 0.0 0.0
Research and development 0.0 0.0 0.0 0.0
Selling, general and administrative 0.0 0.0 0.0 0.0
Amortization of acquired intangibles 0.0 0.0 0.0 0.0
Integration and acquisition costs 0.0 0.0 0.0 0.0
Reorganization costs 0.0 0.0 0.0 0.0
Other operating expenses   0.0   0.0
Gain on sale of product rights 0.0   0.0  
Total operating expenses 0.0 0.0 0.0 0.0
Operating (loss)/income from continuing operations 0.0 0.0 0.0 0.0
Interest income/(expense), net 0.0 0.0 0.0 0.0
Other income, net 0.0 0.0 0.0 0.0
Total other expense, net 0.0 0.0 0.0 0.0
(Loss)/income from continuing operations before income taxes and equity in losses of equity method investees 0.0 0.0 0.0 0.0
Income tax benefit/(expense) 0.0 0.0 0.0 0.0
Equity in income/(losses) of equity method investees, net of taxes (871.0) 477.8 (667.5) 1,089.2
(Loss)/income from continuing operations, net of taxes 871.0 (477.8) 667.5 (1,089.2)
Loss from discontinued operations, net of taxes 0.0 0.0 0.0 0.0
Net (loss)/income 871.0 (477.8) 667.5 (1,089.2)
Comprehensive (loss)/income 871.0 (434.2) 1,055.8 (965.6)
Shire plc (Parent Guarantor)        
Revenues:        
Product sales 0.0 0.0 0.0 0.0
Royalties and other revenues 0.0 0.0 0.0 0.0
Total revenues 0.0 0.0 0.0 0.0
Costs and expenses:        
Cost of sales 0.0 0.0 0.0 0.0
Research and development 0.0 0.0 0.0 0.0
Selling, general and administrative (2.5) 9.0 33.3 22.5
Amortization of acquired intangibles 0.0 0.0 0.0 0.0
Integration and acquisition costs 0.0 0.0 0.0 0.0
Reorganization costs 0.0 0.0 0.0 0.0
Other operating expenses   0.0   0.0
Gain on sale of product rights 0.0   0.0  
Total operating expenses (2.5) 9.0 33.3 22.5
Operating (loss)/income from continuing operations 2.5 (9.0) (33.3) (22.5)
Interest income/(expense), net (23.2) (16.5) (67.7) (46.9)
Other income, net (0.1) 0.1 0.8 1.3
Total other expense, net (23.3) (16.4) (66.9) (45.6)
(Loss)/income from continuing operations before income taxes and equity in losses of equity method investees (20.8) (25.4) (100.2) (68.1)
Income tax benefit/(expense) 0.0 0.4 1.9 1.7
Equity in income/(losses) of equity method investees, net of taxes 366.0 (477.8) 31.6 (1,089.2)
(Loss)/income from continuing operations, net of taxes (386.8) 452.8 (129.9) 1,022.8
Loss from discontinued operations, net of taxes 0.0 0.0 0.0 0.0
Net (loss)/income (386.8) 452.8 (129.9) 1,022.8
Comprehensive (loss)/income (135.2) 409.2 (80.3) 899.2
SAIIDAC (Subsidiary Issuer)        
Revenues:        
Product sales 0.0 0.0 0.0 0.0
Royalties and other revenues 0.0 0.0 0.0 0.0
Total revenues 0.0 0.0 0.0 0.0
Costs and expenses:        
Cost of sales 0.0 0.0 0.0 0.0
Research and development 0.0 0.0 0.0 0.0
Selling, general and administrative 0.0 0.0 0.0 0.0
Amortization of acquired intangibles 0.0 0.0 0.0 0.0
Integration and acquisition costs 0.0 0.0 0.0 0.0
Reorganization costs 0.0 0.0 0.0 0.0
Other operating expenses   0.0   0.0
Gain on sale of product rights 0.0   0.0  
Total operating expenses 0.0 0.0 0.0 0.0
Operating (loss)/income from continuing operations 0.0 0.0 0.0 0.0
Interest income/(expense), net 61.7 0.0 41.5 0.0
Other income, net 0.0 0.0 0.0 0.0
Total other expense, net 61.7 0.0 41.5 0.0
(Loss)/income from continuing operations before income taxes and equity in losses of equity method investees 61.7 0.0 41.5 0.0
Income tax benefit/(expense) (15.4) 0.0 (10.3) 0.0
Equity in income/(losses) of equity method investees, net of taxes 0.0 0.0 0.0 0.0
(Loss)/income from continuing operations, net of taxes 46.3 0.0 31.2 0.0
Loss from discontinued operations, net of taxes 0.0 0.0 0.0 0.0
Net (loss)/income 46.3 0.0 31.2 0.0
Comprehensive (loss)/income 46.3 0.0 31.2 0.0
Baxalta Inc. (Subsidiary Issuer)        
Revenues:        
Product sales 0.0 0.0 0.0 0.0
Royalties and other revenues 0.0 0.0 0.0 0.0
Total revenues 0.0 0.0 0.0 0.0
Costs and expenses:        
Cost of sales 0.0 0.0 0.0 0.0
Research and development 0.0 0.0 0.4 0.0
Selling, general and administrative 10.8 0.0 19.4 0.0
Amortization of acquired intangibles 0.0 0.0 0.0 0.0
Integration and acquisition costs 50.0 0.0 259.7 0.0
Reorganization costs 0.0 0.0 0.0 0.0
Other operating expenses   0.0   0.0
Gain on sale of product rights 0.0   0.0  
Total operating expenses 60.8 0.0 279.5 0.0
Operating (loss)/income from continuing operations (60.8) 0.0 (279.5) 0.0
Interest income/(expense), net (26.1) 0.0 (32.4) 0.0
Other income, net (0.1) 0.0 7.6 0.0
Total other expense, net (26.2) 0.0 (24.8) 0.0
(Loss)/income from continuing operations before income taxes and equity in losses of equity method investees (87.0) 0.0 (304.3) 0.0
Income tax benefit/(expense) 18.9 0.0 77.7 0.0
Equity in income/(losses) of equity method investees, net of taxes 505.0 0.0 635.9 0.0
(Loss)/income from continuing operations, net of taxes (573.1) 0.0 (862.5) 0.0
Loss from discontinued operations, net of taxes 0.0 0.0 0.0 0.0
Net (loss)/income (573.1) 0.0 (862.5) 0.0
Comprehensive (loss)/income (333.4) 0.0 (809.0) 0.0
Non-Guarantor Non-Issuer Subsidiaries        
Revenues:        
Product sales 3,315.4 1,576.8 7,264.8 4,476.2
Royalties and other revenues 136.7 78.2 325.7 224.8
Total revenues 3,452.1 1,655.0 7,590.5 4,701.0
Costs and expenses:        
Cost of sales 1,736.2 262.7 2,762.9 718.5
Research and development 511.1 241.2 1,022.6 1,210.8
Selling, general and administrative 867.3 433.3 1,973.1 1,334.1
Amortization of acquired intangibles 354.9 132.7 702.5 352.3
Integration and acquisition costs 234.5 89.9 478.9 (46.8)
Reorganization costs 101.4 31.1 115.7 59.6
Other operating expenses   (0.7)   (13.0)
Gain on sale of product rights (5.7)   (12.2)  
Total operating expenses 3,799.7 1,190.2 7,043.5 3,615.5
Operating (loss)/income from continuing operations (347.6) 464.8 547.0 1,085.5
Interest income/(expense), net (190.0) 6.6 (248.3) 18.7
Other income, net (13.5) 9.5 (24.6) 10.6
Total other expense, net (203.5) 16.1 (272.9) 29.3
(Loss)/income from continuing operations before income taxes and equity in losses of equity method investees (551.1) 480.9 274.1 1,114.8
Income tax benefit/(expense) 226.1 21.9 149.1 7.3
Equity in income/(losses) of equity method investees, net of taxes 0.9 0.7 1.9 1.6
(Loss)/income from continuing operations, net of taxes (325.9) 502.1 421.3 1,120.5
Loss from discontinued operations, net of taxes (18.3) (24.3) (257.5) (31.3)
Net (loss)/income (344.2) 477.8 163.8 1,089.2
Comprehensive (loss)/income (583.9) 434.2 (278.0) 965.6
Non-Guarantor Subsidiaries of SAIIDAC Notes        
Revenues:        
Product sales 3,315.4 1,576.8 7,264.8 4,476.2
Royalties and other revenues 136.7 78.2 325.7 224.8
Total revenues 3,452.1 1,655.0 7,590.5 4,701.0
Costs and expenses:        
Cost of sales 1,736.2 262.7 2,762.9 718.5
Research and development 511.1 241.2 1,023.0 1,210.8
Selling, general and administrative 878.1 433.3 1,992.5 1,334.1
Amortization of acquired intangibles 354.9 132.7 702.5 352.3
Integration and acquisition costs 284.5 89.9 738.6 (46.8)
Reorganization costs 101.4 31.1 115.7 59.6
Other operating expenses   (0.7)   (13.0)
Gain on sale of product rights (5.7)   (12.2)  
Total operating expenses 3,860.5 1,190.2 7,323.0 3,615.5
Operating (loss)/income from continuing operations (408.4) 464.8 267.5 1,085.5
Interest income/(expense), net (216.1) 6.6 (280.7) 18.7
Other income, net (13.6) 9.5 (17.0) 10.6
Total other expense, net (229.7) 16.1 (297.7) 29.3
(Loss)/income from continuing operations before income taxes and equity in losses of equity method investees (638.1) 480.9 (30.2) 1,114.8
Income tax benefit/(expense) 245.0 21.9 226.8 7.3
Equity in income/(losses) of equity method investees, net of taxes 505.9 0.7 637.8 1.6
(Loss)/income from continuing operations, net of taxes (899.0) 502.1 (441.2) 1,120.5
Loss from discontinued operations, net of taxes (18.3) (24.3) (257.5) (31.3)
Net (loss)/income (917.3) 477.8 (698.7) 1,089.2
Comprehensive (loss)/income (917.3) 434.2 (1,087.0) 965.6
Non-Guarantor Subsidiaries of Baxalta Notes        
Revenues:        
Product sales 3,315.4 1,576.8 7,264.8 4,476.2
Royalties and other revenues 136.7 78.2 325.7 224.8
Total revenues 3,452.1 1,655.0 7,590.5 4,701.0
Costs and expenses:        
Cost of sales 1,736.2 262.7 2,762.9 718.5
Research and development 511.1 241.2 1,022.6 1,210.8
Selling, general and administrative 867.3 433.3 1,973.1 1,334.1
Amortization of acquired intangibles 354.9 132.7 702.5 352.3
Integration and acquisition costs 234.5 89.9 478.9 (46.8)
Reorganization costs 101.4 31.1 115.7 59.6
Other operating expenses   (0.7)   (13.0)
Gain on sale of product rights (5.7)   (12.2)  
Total operating expenses 3,799.7 1,190.2 7,043.5 3,615.5
Operating (loss)/income from continuing operations (347.6) 464.8 547.0 1,085.5
Interest income/(expense), net (128.3) 6.6 (206.8) 18.7
Other income, net (13.5) 9.5 (24.6) 10.6
Total other expense, net (141.8) 16.1 (231.4) 29.3
(Loss)/income from continuing operations before income taxes and equity in losses of equity method investees (489.4) 480.9 315.6 1,114.8
Income tax benefit/(expense) 210.7 21.9 138.8 7.3
Equity in income/(losses) of equity method investees, net of taxes 0.9 0.7 1.9 1.6
(Loss)/income from continuing operations, net of taxes (279.6) 502.1 452.5 1,120.5
Loss from discontinued operations, net of taxes (18.3) (24.3) (257.5) (31.3)
Net (loss)/income (297.9) 477.8 195.0 1,089.2
Comprehensive (loss)/income $ (537.6) $ 434.2 $ (246.8) $ 965.6